new
   Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
506
Nov 06, 2025

Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an innovative oral combination anti-diabetic formulation that integrates the dual advantages of a dipeptidyl peptidase-4 (DPP-4) inhibitor and a biguanide agent.

Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Primary Indication

Adjunctive treatment for type 2 diabetes in adults: Serving as an effective supplement to dietary control and exercise therapy, it is specifically indicated to improve blood glucose control in adult patients with type 2 diabetes.

Special Precautions

Contraindicated Populations: It must not be used for the treatment of patients with type 1 diabetes.

Risk of Pancreatitis: No systematic studies have been conducted in patients with a history of pancreatitis, so it cannot be determined whether the use of this drug in such patients will increase the risk of developing pancreatitis. A rigorous assessment of medication safety is necessary.

Dosage Strengths and Physical Characteristics of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Sitagliptin 100 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "81" on one side as an anti-counterfeiting mark.

Sitagliptin 50 mg / Metformin Hydrochloride 500 mg Extended-Release Tablets

Physical Appearance: Light blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "78" on one side.

Sitagliptin 50 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Light green, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "80" on one side.

Storage Instructions for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Temperature Control Standards

Ideal Storage Temperature: 20°C to 25°C (68°F to 77°F).

Allowable Temperature Fluctuation Range: 15°C to 30°C (59°F to 86°F).

Storage Environment Requirements: Store in a dry area with the container tightly sealed.

Key Points for Packaging Management

Maintenance of Original Packaging: The original packaging must be retained, and the bottle cap must be kept tightly closed.

Child Safety Protection: Store the product in an area that is out of the reach of children.

Usage and Handling Specifications: Reseal the container immediately after each dose is taken.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Storage Conditions for Risdiplam Tablets (Evrysdi)

Proper storage methods ensure the stability and efficacy of the medication.

I. Storage requirements for oral...

Tuesday, June 9th, 2026, 17:35
Pacritinib (Vonjo) Precautions for Administration

Pacritinib is a JAK2/FLT3 inhibitor used for the treatment of splenomegaly or symptoms associated with...

Tuesday, June 9th, 2026, 09:32
Indications and Contraindications of Ruzabrutinib (Wayrilz)

Rezabrutinib is a highly selective BTK inhibitor indicated for various B-cell hematologic malignancies.

I....

Friday, June 5th, 2026, 11:53
Use in Special Populations for Rezabrutinib (Wayrilz)

Patients in different physiological and pathological states have differences in drug metabolism and tolerance....

Friday, June 5th, 2026, 09:54
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved